In this role, you’ll write two to three stories a day and will cover daily news on the biotech and pharma industries. You’ll coordinate closely with our US-based team and our global editors, getting ahead of the American morning to get our coverage out on time.
Stories range from a few hundred words on fast-moving news items like clinical trial results, M&A deals and CEO changes, to longer reporting-driven pieces on business and scientific developments. You’ll react to news and write a lot of copy, and we’re busy enough that there will be ample opportunities for ambitious candidates to hunt scoops and get involved in bigger projects as they learn the beat and grow as a journalist.
You’re the right candidate if you have one to two years of experience covering biotech, pharma or medical science for a trade or specialty publication. You should know what a p-value is and the difference between a biologic and a small molecule, and be ready to expand your skills as a reporter and writer with coaching and support from the team.
This role is part of a group of journalists who report to our deputy editor for newsletters.
To apply, go here.
The Wall Street Journal is looking for an editor to lead its coverage of logistics…
The Wall Street Journal seeks an enterprising and ambitious reporter to cover the intersection of…
The Wall Street Journal is seeking a reporter in Washington, DC, to chronicle one of…
Reuters has hired Wall Street Journal reporter Anna Hirtenstein. She will start next month. Hirtenstein has…
Caroline Gage, head of the Americas for Bloomberg News, sent the following announcement to staff:…
Forbes senior editor Amy Feldman is now covering health care. She had been covering industrial innovation and…